Autorize vs ImmuniWeb® Continuous Penetration Testing: side-by-side comparison (2026)

Autorize: Automatic authorization enforcement detection extension for Burp Suite.

ImmuniWeb® Continuous Penetration Testing: Continuous pentesting service monitoring web apps & APIs for code changes. Built by ImmuniWeb.

The table above shows where their features, integrations, deployment and company size fit differ.

Autorize is open-source with 1,101 GitHub stars. ImmuniWeb® Continuous Penetration Testing is made by ImmuniWeb. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

Often, yes. Autorize and ImmuniWeb® Continuous Penetration Testing are both Penetration Testing products. Key differences: Autorize is Free while ImmuniWeb® Continuous Penetration Testing is Commercial, Autorize is open-source. Use the table above to see where features, deployment and company size fit differ.